Laura Sutcliffe is ranked #1236 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Laura Sutcliffe (Citi) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Laura Sutcliffe's stock ratings?

About 75% of Laura's ratings were profitable over a one-year hold, with an average return of +8.4% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/Laura Sutcliffe

Citi

Laura Sutcliffe

Citi

Wall Street Analyst

★★★☆☆

#1236

on 13Foresight · ranked by our own returns

75%

Success Rate

+8.4%

Average Return

9 of 12 calls profitable · -23596.3% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 75% of Laura Sutcliffe's ratings turned a profit when each position was held for 1 year — averaging +8.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

55 Buy 40 Hold 3 Sell

Laura's Stock Coverage 27 ratings · 2026-07-13

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
RMD Resmed	Jul 10, 2026	HOLD	Buy +14.2% avg upside 27 analysts	$235.00 15.23% Upside	·
AU:RHC Ramsay Health Care	Jul 10, 2026	HOLD	Hold -4.5% avg upside 14 analysts	$42.00 0.67% Downside	·
AU:TLX Telix Pharmaceuticals	Jul 07, 2026	BUY	Strong Buy +56.8% avg upside 13 analysts	$32.00 98.29% Upside	·
AU:ANN Ansell	Jul 06, 2026	HOLD	Buy +6.1% avg upside 9 analysts	$33.50 7.14% Upside	·
AU:PME Pro Medicus Limited	Jul 02, 2026	BUY	Strong Buy +29.6% avg upside 9 analysts	$240.00 20.73% Upside	·
AU:CSL CSL	Jun 30, 2026	HOLD	Strong Buy +47.3% avg upside 15 analysts	$110.00 9.05% Downside	·
AU:SHL Sonic Healthcare Limited	Jun 23, 2026	HOLD	Buy +21.9% avg upside 12 analysts	$19.00 8.84% Downside	·
AU:RMD Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh	Jun 15, 2026	BUY	Strong Buy +42.2% avg upside 11 analysts	$38.00 34.49% Upside	·
AU:COH Cochlear	Apr 22, 2026	SELL	Hold +45.5% avg upside 15 analysts	$95.00 22.55% Downside	·
NL:LKFT Galapagos	May 07, 2024	HOLD	Sell +99.0% avg upside 16 analysts	$34.00 29.26% Upside	·
CH:NOVN Novartis AG	Dec 14, 2022	HOLD	Buy -13.7% avg upside 31 analysts	$84.00 32.38% Downside	·
FR:SAN Sanofi	Aug 09, 2022	HOLD	Strong Buy +28.9% avg upside 30 analysts	$103.00 35.06% Upside	·
SAN Banco Santander SA	Aug 09, 2022	HOLD	Buy -53.5% avg upside 9 analysts	—	+55.6%
GB:GSK GlaxoSmithKline	Aug 08, 2022	HOLD	Hold -3.2% avg upside 25 analysts	$1820.00 7.31% Downside	·
GB:0NZT UCB SA	Jun 27, 2022	HOLD	Buy -8.3% avg upside 19 analysts	$87.00 64.56% Downside	·
GB:0MGB Genmab A/S	May 20, 2022	BUY	Buy +14.7% avg upside 22 analysts	$2600.00 37.51% Upside	·
GMAB Genmab	Mar 16, 2022	BUY	Strong Buy +21.1% avg upside 26 analysts	—	+0.5%
NVS Novartis	Nov 05, 2021	HOLD	Buy -11.8% avg upside 24 analysts	—	+1.8%
ARGX Argenx Se	Jun 18, 2021	BUY	Strong Buy -14.4% avg upside 46 analysts	$390.00 55.53% Downside	+10.0%
LKFT Lakefront Biotherapeutics	Apr 12, 2021	HOLD	Buy +249.3% avg upside 24 analysts	$88.01 190.65% Upside	·
DE:MRK Merck KGaA	Feb 28, 2020	HOLD	Buy -2.6% avg upside 33 analysts	$108.00 22.78% Downside	·
SNY Sanofi	Aug 14, 2019	BUY	Strong Buy +68.9% avg upside 20 analysts	—	+25.0%
GSK GlaxoSmithKline	Feb 22, 2019	HOLD	Buy -17.4% avg upside 19 analysts	—	+11.6%
NVO Novo Nordisk	Aug 08, 2018	HOLD	Buy +134.3% avg upside 26 analysts	$300.00 506.37% Upside	+10.3%
LLY Eli Lilly & Co	Jul 25, 2018	HOLD	Strong Buy -13.5% avg upside 47 analysts	$99.00 91.76% Downside	+14.2%
BMY Bristol-Myers Squibb	Oct 26, 2017	HOLD	Buy +2.3% avg upside 42 analysts	$55.00 4.58% Downside	-15.0%
GILD Gilead Sciences	Oct 18, 2017	BUY	Strong Buy -8.2% avg upside 66 analysts	$96.00 26.03% Downside	-4.5%

🔒 22 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Laura Sutcliffe — Frequently Asked Questions

How accurate are Laura Sutcliffe's stock ratings?

Based on the calls 13Foresight could measure, about 75% of Laura's ratings were profitable over a one-year hold, with an average return of +8.4% per rating, or -23596.3% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Laura ranked on 13Foresight?

Laura Sutcliffe is currently ranked #1236 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Laura cover?

Laura most recently has ratings on RMD, AU:RHC, AU:TLX, AU:ANN, AU:PME, AU:CSL, AU:SHL, AU:RMD, AU:COH, NL:LKFT, CH:NOVN, FR:SAN and 15 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!